Prevention of recurrent thrombosis in the antiphospholipid antibody syndrome: how long and how high with oral anticoagulant therapy?

Ross I Baker
Med J Aust 2004; 180 (9): . || doi: 10.5694/j.1326-5377.2004.tb06015.x
Published online: 3 May 2004

Unravelling the uncertainties

  • Ross I Baker

  • Thrombosis and Haemophilia Unit, Royal Perth Hospital and University of Western Australia, Perth, WA.



remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.